Clinical Trials Register

Trials with a EudraCT protocol (315)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

315 result(s) found for: Oral cavity. Displaying page 2 of 16.

EudraCT Number: 2009-013123-33

Sponsor Protocol Number: 28.5.09

Start Date*: 2009-08-26

Sponsor Name:Tays

Full Title: THE USE OF DEXMEDETOMIDINE IN THE POSTOPERATIVE SEDATION OF HEAD AND NECK CANCER SURGERY

Medical condition: pään ja kaulan alueen syöpäpotilas

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10024534	Lip and/or oral cavity cancer NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed)

Trial results: (No results available)

EudraCT Number: 2019-003416-30	Sponsor Protocol Number: 12175	Start Date*: 2020-12-17
Sponsor Name:Erasmus University Medical Center
Full Title: Guided by Light: Optimizing Surgical Excision of Oral Cancer Using Real-time Fluorescence Imaging
Medical condition: Squamous Cell Carcinoma of the Oral Cavity
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2022-003858-31	Sponsor Protocol Number: 300319	Start Date*: 2023-02-16
Sponsor Name:Aarhus University Hospital
Full Title: Evaluating the vulnerability of traditional and transposition FAMM flaps using microdialysis
Medical condition: Oral cavity cancer and infection
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: (No results available)

EudraCT Number: 2010-019952-35	Sponsor Protocol Number: CS001P3	Start Date*: 2010-09-14
Sponsor Name:CEL-SCI Corporation
Full Title: A Phase III, Open-label, Randomized, Multi-center Study of the Effects of Leukocyte Interleukin, Injection [Multikine] Plus Standard of Care (Surgery + Radiotherapy or Surgery + Concurrent Chemorad...
Medical condition: Subjects with Advanced Primary Sqamous Cell Carcinoma of the oral Cavity/Soft Palate
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: HU (Completed) PL (Completed) GB (GB - no longer in EU/EEA) AT (Prematurely Ended) RO (Ongoing) HR (Completed) ES (Prematurely Ended) IT (Completed)
Trial results: View results

EudraCT Number: 2017-003226-33

Sponsor Protocol Number: 0480

Start Date*: 2018-09-13

Sponsor Name:Dean of the Medical Faculty of the Friedrich-Alexander University Erlangen-Nürnberg Prof. Dr. Markus Neurath

Full Title: First-line treatment of locally advanced HNSCC with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T cell infiltration (CheckRad-CD8)

Medical condition: Locally advanced head and neck squamous cell carcinoma (HNSCC)

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10026518	Malignant neoplasm of supraglottis stage III	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10026519	Malignant neoplasm of supraglottis stage IV	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10026185	Malignant neoplasm of oropharynx, unspecified	LLT
	26.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041862	Squamous cell carcinoma of the oral cavity stage III	LLT
	26.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041863	Squamous cell carcinoma of the oral cavity stage IV	LLT
	26.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041854	Squamous cell carcinoma of the hypopharynx stage III	LLT
	26.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041855	Squamous cell carcinoma of the hypopharynx stage IV	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2021-003554-23

Sponsor Protocol Number: NL68976.041.19

Start Date*: 2021-12-03

Sponsor Name:University Medical Center Utrecht

Full Title: Sentinel lymph node detection in early-stage ORal Cavity squamous cell carcinoma using Magnetic Resonance (MR) lymphogrAphy

Medical condition: The IMP will be used for the identification of sentinel lymph node(s) in patients with early-stage oral cavity squamous cell carcinoma and a clinically negative neck (T1-3, N0, M0).

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004848	10072873	Sentinel lymph node mapping	LLT
	20.1	100000004848	10004822	Biopsy of lymph node	LLT
	21.0	100000004864	10030961	Oral cancer stage unspecified	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2014-003833-24

Sponsor Protocol Number: AGMT_HNO_PN

Start Date*: 2016-06-30

Sponsor Name:AGMT – Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH

Full Title: Randomized phase III study: Supplemental parenteral nutrition for patients with locally advanced inoperable tumors of the head and neck, receiving definitive radiotherapy with Cetuximab or Cisplatin

Medical condition: Locally advanced inoperable tumors of the head and neck under definitive radiotherapy with Cetuximab or Cisplatin

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004864	10031117	Oropharyngeal squamous cell carcinoma stage III	LLT
	20.0	100000004864	10041862	Squamous cell carcinoma of the oral cavity stage III	LLT
	20.0	100000004864	10041863	Squamous cell carcinoma of the oral cavity stage IV	LLT
	20.0	100000004864	10031103	Oropharyngeal cancer stage unspecified	LLT
	20.0	100000004864	10041855	Squamous cell carcinoma of the hypopharynx stage IV	LLT
	20.0	100000004864	10023860	Laryngeal squamous cell carcinoma stage III	LLT
	20.0	100000004864	10041854	Squamous cell carcinoma of the hypopharynx stage III	LLT
	20.0	100000004864	10023861	Laryngeal squamous cell carcinoma stage IV	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2012-001416-27	Sponsor Protocol Number: MEC-2012-130	Start Date*: 2012-11-15
Sponsor Name:Erasmus MC
Full Title: Treatment of Cancer in the head and Neck: The Role of Hyperbaric Oxygen in Reducing Swallowing Problems
Medical condition: Nasopharynx, Oropharynx, Oral Cavity, Hypopharynx, Larynx
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2014-002135-34

Sponsor Protocol Number: IPH2201-201

Start Date*: 2014-10-20

Sponsor Name:Innate Pharma

Full Title: Open label single arm Phase Ib-II study of pre-operative IPH2201 in patients with locally advanced resectable squamous cell carcinoma of the oral cavity

Medical condition: Locally advanced resectable squamous cell carcinoma of the oral cavity

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10071536	Head and neck cancer stage IV	PT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10071537	Head and neck cancer stage III	PT
	18.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10071538	Head and neck cancer stage II	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2004-002016-28

Sponsor Protocol Number: 20040118

Start Date*: 2005-01-04

Sponsor Name:Amgen

Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduct...

Medical condition: Oral mucositis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.1	100000004856	10028130	Mucositis oral	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) AT (Completed) IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-004107-37	Sponsor Protocol Number: HNBE-03-01	Start Date*: 2004-11-12
Sponsor Name:Genetronics Biomedical Corporation
Full Title: A Randomized Trial Comparing Preservation of Function Status After Either MedPulser® Electroporation with Intraumoral Bleomycin Therapy or Surgery in Patients with Locally Recurrent or Second Prima...
Medical condition: Patients with locally recurrent or second primary SCC of the anterior oral cavity, soft palate, and tonsil that have failed primary curative therapy in whom surgical resection is seen as an option ...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: LV (Completed) GB (Prematurely Ended)
Trial results: View results

EudraCT Number: 2017-003675-61

Sponsor Protocol Number: D3252C00001

Start Date*: 2017-12-21

Sponsor Name:AstraZeneca AB

Full Title: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients with Severe Nasal Polyposis

Medical condition: Nasal polyposis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004855	10028754	Nasal polyp	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed) AT (Completed) BE (Completed) HU (Completed) PL (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2013-003323-11

Sponsor Protocol Number: ITIBU001

Start Date*: 2014-10-01

Sponsor Name:"Sapienza" University of Rome

Full Title: RANDOMIZED CLINICAL TRIAL, PLACEBO-CONTROLLED, SPLIT-MOUTH, A DOUBLE-BLIND, FOR THE EVALUATION OF THE EFFECTIVENESS OF PREemptive ANALGESIA BY ADMINISTRATION OF IBUPROFEN 400MG, FOR THE CONTROL ...

Medical condition: POST-OPERATIVE ACUTE PAIN (DAPO)

Disease:	Version	SOC Term	Classification Code	Term	Level
	17.1	10017947 - Gastrointestinal disorders	10031009	Oral pain	PT
	17.1	10017947 - Gastrointestinal disorders	10030973	Oral discomfort	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2011-002542-12

Sponsor Protocol Number: IEOS629/411

Start Date*: 2012-09-19

Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA

Full Title: Lymphatic mapping in oropharyngeal neoplasms: comparison between Dynamic Lymphoscintigrafy and Fluorescence Lymphografy using indocyanine green dye (ICG). Validation study.

Medical condition: - Epithelial Carcinoma of the oral cavity and oropharynx

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10034819	Pharyngeal cancer stage unspecified	PT
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10024534	Lip and/or oral cavity cancer NOS	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2012-002287-26

Sponsor Protocol Number: GN12CO201

Start Date*: 2012-10-24

Sponsor Name:Greater Glasgow and Clyde NHS Board [...]

Full Title: Comparison of the caries-protective effect of fluoride varnish (Duraphat®) with treatment as usual in nursery school attenders receiving preventive oral health support through the Childsmile Progra...

Medical condition: Childhood dental caries

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10017947 - Gastrointestinal disorders	10012318	Dental caries	PT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2019-004052-11

Sponsor Protocol Number: UC-HNG/1909

Start Date*: 2020-07-08

Sponsor Name:UNICANCER

Full Title: A phase II trial assessing Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in a pre-operative setting for resectable and untreated head and neck squamous cell carcinoma

Medical condition: Histologically or cytologically confirmed squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx, previously untreated, with indication of primary surgery. Patients with a di...

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041824	Squamous cell carcinoma of esophagus	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041859	Squamous cell carcinoma of the oral cavity stage 0	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041860	Squamous cell carcinoma of the oral cavity stage I	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041861	Squamous cell carcinoma of the oral cavity stage II	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041862	Squamous cell carcinoma of the oral cavity stage III	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041863	Squamous cell carcinoma of the oral cavity stage IV	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10031113	Oropharyngeal squamous cell carcinoma recurrent	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10031114	Oropharyngeal squamous cell carcinoma stage 0	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10031115	Oropharyngeal squamous cell carcinoma stage I	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10021052	Hypopharyngeal squamous cell carcinoma recurrent	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10021053	Hypopharyngeal squamous cell carcinoma stage 0	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10021055	Hypopharyngeal squamous cell carcinoma stage II	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10021054	Hypopharyngeal squamous cell carcinoma stage I	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041854	Squamous cell carcinoma of the hypopharynx stage III	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041853	Squamous cell carcinoma of the hypopharynx stage II	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041855	Squamous cell carcinoma of the hypopharynx stage IV	LLT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10023856	Laryngeal squamous cell carcinoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: View results

EudraCT Number: 2008-002340-42

Sponsor Protocol Number: SBG-2-03

Start Date*: 2008-09-16

Sponsor Name:Biotec Pharmacon ASA

Full Title: A randomized, double-blind, placebo-controlled, parallel-group phase III clinical study to assess the efficacy and safety of soluble beta 1,3/1,6 glucan (SBG) on oral mucositis in head and neck can...

Medical condition: Oral mucositis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10028130	Mucositis oral	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) DE (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000213-35

Sponsor Protocol Number: 20020402

Start Date*: 2005-08-05

Sponsor Name:Swedish Orphan Biovitrum AB (publ.)

Medical condition: Oral mucositis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.1	100000004856	10028130	Mucositis oral	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) HU (Completed) AT (Completed) DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2011-004887-31

Sponsor Protocol Number: OPN-FLU-NP-3102

Start Date*: 2014-11-04

Sponsor Name:OptiNose US, Inc

Full Title: A 16-Week RaNdomized, Double-Blind, Placebo-Controlled, PArallel-Group, Multicenter Study EValuatInG the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of FluticAsone Prop...

Medical condition: Bilateral Nasal Polyposis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.0	100000004855	10028754	Nasal polyp	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2017-000577-36	Sponsor Protocol Number: S60379	Start Date*: 2018-08-27
Sponsor Name:University Hospitals Leuven
Full Title: Durvalumab (MEDI4736) plus tremelimumab in resectable, locally advanced squamous cell carcinoma of the oral cavity: a window of opportunity study
Medical condition: resectable, locally advanced squamous cell carcinoma of the oral cavity
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Trial now transitioned)
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Oral cavity